Cyberonics Inc. Presents at 17th Annual BURKENROAD REPORTS Investment Conference, Apr-26-2013 09:30 AM. Venue: Westin New Orleans Canal Place Hotel, 100 Rue Iberville, New Orleans, LA 70130, United States. Speakers: Gregory H. Browne, Chief Financial Officer, Principal Accounting Officer and Senior Vice President of Finance.

Cyberonics Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended January 25, 2013. For the quarter, the company’s net sales were $62,700,033 against $54,536,585 a year ago. Income from operations was $20,441,558 against $16,398,243 a year ago. Income before income taxes was $20,331,929 against $16,143,089 a year ago. Net income was $13,183,494 or $0.47 per diluted share against $9,502,184 or $0.34 per basic and diluted share a year ago. For the nine months, the company’s net sales were $185,976,849 against $160,893,723 a year ago. Income from operations was $57,882,878 against $42,975,169 a year ago. Income before income taxes was $54,915,005 against $42,487,585 a year ago. Net income was $34,825,431 or $1.24 per diluted share against $25,414,512 or $0.90 per diluted share a year ago. Net cash provided by operating activities was $55,705,285 against $52,736,061 a year ago. Intangible asset purchases were $2,500,000 against $500,000 a year ago. Purchases of property, plant and equipment was $6,515,509 against $16,586,464 a year ago. Adjusted EBITDA was $23,828,219 against $20,847,276 a year ago. For the year 2013, net sales guidance in the range from $248 million to $250 million against $246 million to $249 million previous guidance. Income from operations (now inclusive of the medical device tax) in the range from $75 million to $77 million against $73 million to $75 million exclusive of the medical device tax previous guidance. Adjusted net income in the range from $46 million to $48 million against $43 million to $45 million previous guidance. Adjusted diluted earnings per share in the range from $1.66 to $1.72 against $1.56 to $1.62 previous guidance. Guidance for adjusted net income and adjusted diluted earnings per share excludes a loss of $2.5 million (net of tax), or $0.09 per share, for an investment write-down in the first quarter, and a gain on warrant liability of $1.3 million, or $0.05 per share.

Cyberonics Inc. Presents at Barclays Global Healthcare Conference, Mar-12-2013 01:30 PM. Venue: Lowes Miami Hotel, Miami, Florida, United States. Speakers: Daniel Jeffrey Moore, Chief Executive Officer, President and Executive Director.